Paolo Guido Camici

Paolo Guido Camici's AcademicInfluence.com Rankings

Paolo Guido Camici

Medical

#1611

World Rank

#1969

Historical Rank

Cardiology

#127

World Rank

#130

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Paolo Guido Camici Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paolo Guido Camici's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. (2005) (1768)
Coronary microvascular dysfunction. (2013) (860)
[Guidelines on the management of stable angina pectoris: executive summary]. (2006) (705)
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. (2003) (682)
Coronary microvascular dysfunction: an update. (2014) (543)
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. (2013) (490)
Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes (2014) (435)
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade (2017) (421)
Hibernating myocardium. (1998) (398)
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. (2008) (387)
International standardization of diagnostic criteria for microvascular angina. (2018) (381)
Stunning, Hibernation, and Assessment of Myocardial Viability (2008) (367)
Coronary microvascular dysfunction: mechanisms and functional assessment (2015) (344)
Pathophysiological dilemma of syndrome X. (1992) (342)
Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. (2001) (336)
Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. (1991) (331)
Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries (2002) (316)
From endothelial dysfunction to atherosclerosis. (2010) (298)
[Guidelines for percutaneous coronary interventions]. (2005) (296)
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. (1989) (288)
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (278)
Myocardial blood flow measurement by PET: technical aspects and clinical applications. (2005) (272)
Pathophysiology of Takotsubo Syndrome (2017) (265)
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. (2006) (264)
The case for myocardial ischemia in hypertrophic cardiomyopathy. (2009) (262)
Central nervous pathways mediating angina pectoris (1994) (258)
Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. (1986) (248)
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. (2012) (245)
Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function (2000) (241)
Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. (1999) (233)
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. (1991) (232)
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. (2006) (218)
Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. (1982) (217)
alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. (2000) (214)
Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. (2015) (208)
Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis (2003) (205)
Silent Ischemia as a Central Problem: Regional Brain Activation Compared in Silent and Painful Myocardial Ischemia (1996) (201)
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy (2020) (201)
Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. (1993) (194)
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. (2009) (193)
Cardiac sympathetic imaging with mIBG in heart failure. (2010) (191)
Coronary Vasodilator Reserve, Pain Perception, and Sex in Patients With Syndrome X (1994) (189)
Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. (2000) (188)
The Clinical Value of Myocardial Blood Flow Measurement* (2009) (187)
Effect of aging on myocardial perfusion reserve. (1995) (178)
Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. (1998) (172)
Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). (1997) (167)
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry (2018) (164)
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. (1996) (163)
Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. (2015) (158)
Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. (1990) (158)
Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes. (2017) (158)
Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease (2017) (156)
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. (2002) (154)
Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. (2000) (150)
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. (2010) (149)
Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A (2005) (147)
Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure (1998) (146)
Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis (2015) (145)
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis (2017) (144)
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. (2013) (144)
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 (2020) (143)
The coronary circulation and blood flow in left ventricular hypertrophy. (2012) (137)
Program of Cell Survival Underlying Human and Experimental Hibernating Myocardium (2004) (136)
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. (2011) (134)
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. (2012) (132)
Insulin resistance in patients with cardiac hypertrophy. (1999) (131)
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. (2006) (131)
Coronary Reserve and Exercise ECG in Patients With Chest Pain and Normal Coronary Angiograms (1992) (131)
Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris (2018) (130)
Metabolic and hemodynamic effects of insulin on human hearts. (1993) (127)
Central neural contribution to the perception of chest pain in cardiac syndrome X (2002) (127)
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. (2010) (126)
Evaluation of the microcirculation in hypertension and cardiovascular disease. (2007) (124)
The role of T and B cells in human atherosclerosis and atherothrombosis (2015) (121)
Assessment of myocardial ischaemia and viability: role of positron emission tomography. (2010) (121)
The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. (2016) (119)
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. (1998) (114)
Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols (1998) (114)
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. (2019) (109)
Impairment of coronary flow reserve in aortic stenosis. (2009) (108)
Novel insights into an "old" phenomenon: the no reflow. (2015) (106)
123I-mIBG Scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials (2009) (106)
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. (2008) (105)
Expert consensus document: A 'diamond' approach to personalized treatment of angina (2018) (105)
Coronary microvascular resistance: methods for its quantification in humans (2009) (104)
Optimized Treatment of ST-Elevation Myocardial Infarction. (2019) (103)
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. (2012) (103)
Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. (1999) (102)
Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. (1998) (100)
Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome (2004) (99)
Respiratory gating of cardiac PET data in list-mode acquisition (2006) (99)
Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. (1997) (98)
From Left Ventricular Hypertrophy to Dysfunction and Failure. (2016) (97)
Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation. (2002) (95)
Relationship Between Regional Myocardial Oxygenation and Perfusion in Patients With Coronary Artery Disease: Insights From Cardiovascular Magnetic Resonance and Positron Emission Tomography (2010) (93)
Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. (2016) (91)
Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. (1989) (91)
Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. (1998) (91)
The heart failure revascularisation trial (HEART): rationale, design and methodology (2003) (86)
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. (2006) (84)
Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. (1994) (83)
Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-de (2001) (80)
Role of positron emission tomography in the investigation of human coronary circulatory function. (1994) (79)
Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. (2002) (78)
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study (2018) (78)
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. (2012) (77)
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease (2020) (76)
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension (2011) (76)
Detection and Quantification of Large-Vessel Inflammation with 11C-(R)-PK11195 PET/CT (2011) (75)
Coronary microvascular dysfunction in hypertrophy and heart failure. (2020) (75)
Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy (2008) (74)
Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment (1999) (73)
Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection (2021) (73)
Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. (1998) (71)
Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. (1998) (71)
Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival (1999) (71)
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake (2000) (71)
Advances in coronary microvascular dysfunction. (2009) (69)
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study. (2019) (69)
Cardiovascular disease and brain health: Focus on white matter hyperintensities (2018) (68)
Commentary: The new ESC guidelines for the diagnosis and management of chronic coronary syndromes. (2019) (66)
The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis (2019) (65)
Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. (2002) (64)
The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. (1996) (64)
Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. (2002) (63)
Routine Screening of Coronary Artery Disease With Computed Tomographic Coronary Angiography in Place of Invasive Coronary Angiography in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (63)
Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy. (1996) (62)
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. (2019) (60)
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. (2002) (59)
Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. (2015) (59)
Methods to investigate coronary microvascular function in clinical practice (2013) (57)
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. (2010) (55)
Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. (2002) (55)
Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization. (1998) (55)
"In vivo" imaging of atherosclerosis. (2012) (54)
Cardiomyopathy in Duchenne, Becker, and sarcoglycanopathies: A role for coronary dysfunction? (1999) (54)
Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy (2009) (53)
Efficacy of coronary angioplasty for the treatment of hibernating myocardium (1999) (53)
Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different. (2016) (53)
Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis. (2016) (52)
Positron emission tomography and myocardial imaging (2000) (50)
CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia. (2016) (50)
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes (2002) (50)
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group (2021) (49)
Dobutamine stress: effects on regional myocardial blood flow and wall motion. (1995) (49)
Myocardial blood flow in patients with hibernating myocardium. (2003) (49)
Myocardial beta adrenoceptor density in primary and secondary left ventricular hypertrophy. (1996) (47)
Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles (1999) (47)
Right ventricular remodelling in systemic hypertension: a cardiac MRI study (2011) (47)
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. (1998) (47)
Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study. (2007) (47)
Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium (2001) (47)
Glutathione depletion increases chemiluminescence emission and lipid peroxidation in the heart. (1984) (47)
Evaluation of [11C]GB67, a novel radioligand for imaging myocardial α1-adrenoceptors with positron emission tomography (2000) (46)
The brain-heart axis in the perception of cardiac Pain: the elusive link between ischaemia and pain (2000) (46)
Correlation between hydroperoxide-induced chemiluminescence of the heart and its function. (1983) (45)
Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study (2003) (45)
Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog's heart. (1980) (44)
Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis. (2017) (44)
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis (2022) (44)
Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. (2005) (44)
Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link. (2001) (44)
Takotsubo is not a cardiomyopathy. (2017) (44)
Effect of alpha 1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. (1996) (43)
Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment (2018) (42)
Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? (2005) (40)
Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. (1997) (39)
Non-invasive molecular imaging of vulnerable atherosclerotic plaques. (2015) (39)
Adrenergically mediated coronary vasoconstriction in patients with Syndrome X (1994) (38)
Metabolic Markers of Stress‐Induced Myocardial Ischemia (1991) (38)
Contemporary survival trends and aetiological characterization in non‐ischaemic dilated cardiomyopathy (2020) (37)
Circulating CD14+ and CD14highCD16- classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid artery. (2016) (37)
Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction. (2016) (36)
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium (2002) (36)
Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia (2000) (35)
Coronary effects of adenosine in conscious man. (1989) (35)
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. (2006) (35)
In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. (2002) (35)
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC]. (2005) (35)
Persistent but reversible coronary microvascular dysfunction after bypass grafting. (2000) (34)
Systemic Inhibition of Nitric Oxide Synthase Unmasks Neural Constraint of Maximal Myocardial Blood Flow in Humans (2004) (34)
The European Registry of Cardiac Catheter Interventions 1997. (2002) (34)
Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation. (2006) (33)
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. (2004) (33)
Non-Invasive Imaging of Vascular Inflammation (2014) (33)
ST-Segment–Elevation Myocardial Infarction During COVID-19 Pandemic (2020) (32)
Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron-emission tomography (1991) (32)
The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure (2014) (32)
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (32)
Predictors of Long-Term Mortality in Patients with Myocardial Infarction and Nonobstructed Coronary Arteries: A Systematic Review and Meta-Regression Study. (2019) (31)
Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: a study with transesophageal echocardiography and positron emission tomography with oxygen 15 water. (1995) (31)
Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique (2002) (31)
Coronary microvascular dysfunction in primary cardiomyopathies (2013) (31)
Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography (1988) (31)
Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography (1996) (31)
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy. (2013) (31)
[Guidelines on the management of stable angina pectoris. Executive summary]. (2006) (30)
The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function. (2004) (30)
Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat (2012) (29)
Effect of α1-Adrenoceptor Blockade on Coronary Vasodilator Reserve in Cardiac Syndrome X (1999) (28)
Regional myocardial blood flow redistribution as a cause of postprandial angina pectoris. (1998) (28)
Selection, design and evaluation of new radioligands for PET studies of cardiac adrenoceptors. (2000) (27)
The many faces of myocardial ischemia and angina. (2019) (26)
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. (2018) (26)
Identification of High-Risk Patients After ST-Segment–Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters (2017) (26)
Biodistribution and metabolism of [N-methyl-11C]m-hydroxyephedrine in the rat. (1997) (26)
Spontaneous Dissecting Aneurysm of the Aorta in a Dog (1981) (25)
Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. (1996) (25)
Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure. (2010) (25)
Dipyridamole Echocardiography Stress Testing in Hypertensive Patients: Targets and Tools (1991) (25)
Positron emission tomography for quantitation of myocardial perfusion (2004) (25)
Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: implications for pharmacologic stress testing in coronary artery disease (2006) (24)
Chronic Ischaemic Heart Disease (2009) (24)
Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus. (2018) (24)
Linear dimension reduction of sequences of medical images: II. Direct sum decomposition. (1995) (24)
Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases. (1999) (24)
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction (2002) (23)
Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography. (1986) (23)
Microvascular angina: a women's affair? (2015) (23)
Analysis of the electrocardiographic QT interval in patients with syndrome X. (1994) (23)
Association of White Matter Hyperintensities and Cardiovascular Disease (2020) (23)
Myocardial infarction with non-obstructive coronary arteries: what is the prognosis? (2020) (23)
Is central nervous system processing altered in patients with heart failure? (2004) (22)
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy (2009) (22)
Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography (2007) (21)
Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina: Ethnic differences detected in an international comparative study. (2019) (21)
Effects of Long-Term Oral Dipyridamole Treatment on Coronary Microcirculatory Function in Patients With Chronic Stable Angina: A Substudy of the Persantine In Stable Angina (PISA) Study (2006) (21)
Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. (2004) (21)
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia (2004) (21)
Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction? (2011) (20)
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia (2005) (20)
Response by Ammirati et al to Letter Regarding Article, "Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis". (2019) (20)
Hibernation and heart failure (2004) (20)
Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with an alpha1-adrenergic antagonist. (2000) (20)
Time-dependent response of coronary flow to prolonged adenosine infusion: doubling of peak reactive hyperaemic flow. (1981) (19)
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients (2017) (19)
Hibernation and Congestive Heart Failure (2003) (19)
Pre- and post-synaptic sympathetic function in human hibernating myocardium (2007) (19)
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy (2005) (19)
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart (2007) (18)
Myocardial ischemia: From disease to syndrome. (2020) (18)
Anti-anginal drugs: Systematic review and clinical implications. (2019) (18)
The contribution of hibernation to heart failure (2004) (18)
Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation. (2014) (17)
Positron emission tomography using 18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: Optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction (2001) (17)
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias (2021) (17)
Circadian Rhythms of Heart Rate Variability in Hypertrophic Cardiomyopathy (1996) (17)
Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis - limited vs. diffuse form. (2015) (17)
The Role of Positron Emission Tomography (2013) (16)
Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies. (2019) (16)
Quantification of [11C]GB67 binding to cardiac α1-adrenoceptors with positron emission tomography: validation in pigs (2008) (16)
Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction (2002) (16)
Myocardial hibernation vs repetitive stunning in patients. (1999) (16)
Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. (2021) (16)
Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization. (2019) (15)
Preparation of no‐carrier‐added [124I]A14‐iodoinsulin as a radiotracer for positron emission tomography (2001) (15)
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses. (2007) (15)
Viral genome search in myocardium of patients with fulminant myocarditis (2020) (15)
Effects of Gender on Coronary Microvascular Dysfunction and Cardiac Outcomes (2014) (15)
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? (2002) (14)
of the working group Coronary Circulation of the European Society of Cardiology (2002) (14)
Calculation of single detector efficiencies and extension of the normalization sinogram in PET. (1997) (14)
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study (2021) (14)
The predictive role of renal function and systemic inflammation on the onset of de novo atrial fibrillation after cardiac surgery (2016) (14)
Myocardial revascularization for the treatment of post-ischemic heart failure. (1999) (14)
Does positron emission tomography contribute to the management of clinical cardiac problems? (1996) (14)
Microcirculation: what is the role of calcium antagonists? (1997) (13)
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis (2019) (13)
Evidence for a systemic defect of resistance‐sized arterioles in hypertrophic cardiomyopathy (1993) (13)
Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia (2015) (13)
Identifying Myocardial Ischemia due to Coronary Microvascular Dysfunction in the Emergency Department: Introducing a New Paradigm in Acute Chest Pain Evaluation. (2018) (13)
Transcriptional Network Analysis for the Regulation of Left Ventricular Hypertrophy and Microvascular Remodeling (2013) (13)
Impact of Cardiovascular Risk Factors and Pharmacologic Treatments on Carotid Intraplaque Neovascularization Detected by Contrast‐Enhanced Ultrasound (2019) (13)
Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption (2006) (13)
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification. (2020) (13)
Calcified left ventricular endomyocardial fibrosis. (2012) (13)
Revascularisation for post-ischaemic heart failure: How myocardial viability affects survival (1999) (12)
Hypertrophic cardiomyopathy: The need for randomized trials (2013) (12)
Noninvasive identification of limited coronary flow reserve in hypertrophic cardiomyopathy (1992) (12)
Medical Misinformation. (2019) (12)
Acute Myocarditis Associated With Desmosomal Gene Variants. (2022) (12)
Pulmonary β adrenoceptor density in arrhythmogenic right ventricular cardiomyopathy and idiopathic tachycardia (2001) (11)
Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum. (2009) (11)
Comparison of analytic and iterative reconstruction methods for quantitative cardiac PET studies in 3D using Oxygen-15 water scans (2005) (11)
Progression of brain white matter hyperintensities in asymptomatic patients with carotid atherosclerotic plaques and no indication for revascularization. (2019) (11)
The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review. (2021) (11)
Revascularisation for chronic heart failure: a valid option? (1999) (11)
Regional myocardial glucose metabolism in angina pectoris obtained from positron emission tomography. (1988) (10)
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity. (2021) (10)
Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia. (1992) (10)
Gated PET and ventricular volume. (2003) (10)
Takotsubo syndrome's pathophysiology: still a mystery? (2019) (10)
The contribution of positron emission tomography to the study of ischemic heart failure. (2001) (10)
Effect of different drug classes on reverse remodeling of intramural coronary arterioles in the spontaneously hypertensive rat (2017) (10)
Normal values for left ventricular volumes obtained using gated PET. (1998) (10)
The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach (2021) (10)
3D imaging and morphometry of the heart capillary system in spontaneously hypertensive rats and normotensive controls (2020) (10)
Reduction of Circulating HLA-DR+ T Cell Levels Correlates With Increased Carotid Intraplaque Neovascularization and Atherosclerotic Burden. (2016) (10)
Coronary microvascular dysfunction in patients with cardiomyopathies. (2008) (10)
International prospective cohort study of microvascular angina – Rationale and design (2020) (10)
Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics. (2017) (9)
Myocardial pre- and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy (1997) (9)
Absolute figures are better than percentages. (2009) (9)
POSITRON EMISSION TOMOGRAPHY Increased uptake of 18 F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina (2005) (9)
Cardiac nociception. (2006) (9)
Blood flow in myocardial hibernation. (1998) (9)
New concepts in fulminant myocarditis and risk of cardiac mortality (2017) (8)
Hibernation and myocardial ischemia: Clinical detection by positron emission tomography (1992) (8)
Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering. (2017) (8)
Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function. (1997) (8)
Role of ivabradine in management of stable angina in patients with different clinical profiles (2018) (8)
Parametric polar maps of regional myocardial beta-adrenoceptor density. (1999) (8)
Carotid artery plaque uptake of 11C-PK11195 inversely correlates with circulating monocytes and classical CD14++CD16− monocytes expressing HLA-DR (2018) (8)
From microcirculation to cardiac event: protection with Preterax. (2008) (8)
Medical Misinformation: Vet the Message! (2019) (8)
A report system for PET assessment of myocardial viability. (1999) (8)
Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis. (2013) (8)
The value of quantitative myocardial perfusion imaging with Positron Emission Tomography in coronary artery disease (1997) (8)
Imaging of cardiac adrenergic innervation (2002) (8)
Effects of ergotamine on myocardial blood flow in migraineurs without evidence of atherosclerotic coronary artery disease. (1998) (8)
Different respiratory activities of mitochondria isolated from the subendocardium and subepicardium of the canine heart (1984) (7)
Commentary - The ISCHEMIA trial. (2020) (7)
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF (2019) (7)
Regional brain activation compared in silent and painful myocardial ischaemia (1995) (7)
Molecular imaging of vascular inflammation (2010) (7)
Uneven myocardial glucose utilization as determined by regional 14C-deoxyglucose uptake. (1979) (7)
Stochastic and Exponential Analysis of Precordial Washout Curves for Myocardial Blood Flow Measurement (1981) (7)
Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab (2021) (7)
Erratum: Persistent but reversible coronary microvascular dysfunction after bypass grafting (American Journal of Physiology - Heart and Circulatory Physiology (December 2000) 279 (H2634-H2640)) (2001) (7)
An additional marker for familial hypertrophic cardiomyopathy? (1993) (7)
Cardiac and respiratory gating of list-mode data on a high sensitivity PET scanner, the ECAT EXACT3D (1999) (7)
Fractal analysis of plaque border, a novel method for the quantification of atherosclerotic plaque contour irregularity, is associated with pro-atherogenic plasma lipid profile in subjects with non-obstructive carotid stenoses (2018) (7)
Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: the contribution of PET (2003) (7)
A new technique for the simultaneous assessment of myocardial perfusion and contractility in man (1981) (6)
Regional myocardial glucose utilization assessed by (14C) deoxyglucose (1981) (6)
Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X. (1999) (6)
[Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse form of the disease]. (2014) (6)
Left ventricular remodelling 6 months after infarction is predicted by myocardial β-adrenoceptor density at 1 month (1998) (6)
Abnormal coronary flow reserve in syndrome X: a critical view off the concept of vasodilator reserve and its relation to ischemia (1992) (6)
Syndrome X: background, clinical aspects, pathophysiology & treatment. (1994) (6)
A new technique for multitracer macroscopic autoradiography. (1981) (6)
Insights into the Pathophysiology of Syndrome X Obtained Using Positron Emission Tomography (PET) (1999) (6)
Radionuclide PET and PET/CT in coronary artery disease. (2008) (6)
Combined checkpoint inhibitor-associated myocarditis and pulmonary vasculitis mimicking acute pulmonary embolism. (2018) (6)
List-Mode Affine Rebinning for Respiratory Motion Correction in PET Cardiac Imaging (2006) (6)
Syndrome X: radionuclide studies of myocardial perfusion in patients with chest pain and normal coronary arteriograms (2004) (6)
Coronary stenosis and transmural perfusion across the left ventricular wall. (2014) (6)
Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international. (2022) (5)
How important is microcirculation in clinical practice? (2019) (5)
Beneficial effect of nitrates on myocardial glucose utilization in unstable angina pectoris. (1987) (5)
Still poor prognosis for patients with giant cell myocarditis in the era of temporary mechanical circulatory supports. (2018) (5)
Prolonged metabolic recovery allows late identification of ischemia in the absence of electrocardiographic and perfusion changes in patients with exertional angina. (1986) (5)
Optimized Treatment of ST-Elevation Myocardial Infarction: The Unmet Need to Target Coronary Microvascular Obstruction as Primary Treatment Goal to Further Improve Prognosis (2019) (5)
Variability of the lumped constant for [18F]2-deoxy-2-fluoroglucose and the experimental isolated rat heart model: clinical perspectives for the measurement of myocardial tissue viability in humans. (1999) (5)
Changes of late gadolinium enhancement extension compared with native T1 mapping early after acute myocarditis. (2018) (5)
Patent foramen ovale closure and brain ischaemic lesions (2013) (5)
Regional myocardial deoxyglucose uptake following electrical stimulation of canine efferent sympathetic cardiopulmonary nerves. (1992) (5)
The Effect of Aging On Coronary Flow Reserve in Man (1993) (5)
Cardiac PET Motion Correction Using Materially Constrained Transform Models (2008) (5)
Imaging of Vascular Inflammation with [C]-PK11195 and PET/CT Angiography (2015) (5)
Malignancy in patients with myocardial infarction and non-obstructive coronary arteries: A systematic review and meta-regression. (2020) (5)
Sunday, 26 August 2012 (2012) (5)
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (2019) (5)
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study. (2020) (5)
Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension (1994) (4)
Advances in SPECT and PET for the management of heart failure (2010) (4)
Digital Autoradiography: Film and Electronic Multitracer Techniques for Heart Imaging (1984) (4)
[ANMCO/SIC Consensus document on the management of myocarditis]. (2020) (4)
Assessment of myocardial perfusion, metabolism and pharmacology using positron emission tomography. (1992) (4)
Physiology of Coronary Microcirculation (2014) (4)
Medical Misinformation: Vet the Message! (2019) (4)
Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". (2015) (4)
Digital Imaging of Regional Glucose Metabolism of the Heart with a MWPC (1983) (4)
Positron emission tomography to assess the haemodynamics of the coronary circulation. (1998) (4)
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology. (2017) (4)
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization (2020) (4)
PET measurement of the coronary flow reserve and microcirculatory function (1999) (4)
Noninvasive assessment of regional coronary flow reserve BY dipyridamole echocardiography: Correlation with 13N-ammonia and positron emission tomography (1990) (4)
Coronary microvascular dysfunction and flow reserve: an update (2013) (4)
Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions (2015) (4)
Coronary microvascular dysfunction in heart failure with preserved ejection fraction – adding new pieces to the jigsaw puzzle (2020) (3)
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis (2019) (3)
Why the Term MINOCA Does Not Provide Conceptual Clarity for Actionable Decision-Making in Patients with Myocardial Infarction with No Obstructive Coronary Artery Disease (2021) (3)
Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium. (1996) (3)
Monday, 27 August 2012 (2012) (3)
A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial. (2011) (3)
Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy (2020) (3)
Cardiovascular Drugs and the Management of Heart Disease (1992) (3)
Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment? (2014) (3)
WITHDRAWN: Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection (2021) (3)
Assessment of myocardial viability and the role of surgery (1993) (3)
Correction of respiratory motion in dual gated cardiac imaging in PET/CT (2008) (3)
Integrated clinical role of echocardiography in patients with COVID-19 (2020) (3)
Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (2022) (3)
Association of outcome with left ventricular parameters measured by two- and three-dimensional echocardiography (2009) (3)
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy (2022) (3)
Effect of lacidipine on coronary vasodilator reserve in hypertensive patients: a study with positron emission tomography (1991) (3)
5 – Coronary Microvascular Dysfunction (2018) (3)
Measurement of ultraweak chemiluminescence emitted from isolated and perfused rat hearts (1984) (3)
TREATMENT OF HYPERTENSION WITH PERINDOPRIL PLUS INDAPAMIDE LEADS TO REVERSE CORONARY MICROVASCULAR REMODELLING AND IMPROVED BLOOD FLOW: 3D.05 (2010) (3)
Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead. (2017) (3)
P5142Survival and left ventricular function changes in fulminant versus non-fulminant acute myocarditis (2017) (2)
Studies Of Coronary Blood Flow And Myocardial Metabolism In Patients With Chest Pain And Angiographically Normal Coronary Arteries (1994) (2)
Assessment of Myocardial Viability Using 15O-Water (1996) (2)
A new technique for gated reconstruction applied to microsphere myocardial imaging (1980) (2)
A novel (18)F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography: another way to avoid the need of an on-site cyclotron. (2009) (2)
Trabecular complexity as an early marker of cardiac involvement in Fabry disease. (2021) (2)
Medical misinformation: vet the message! (2019) (2)
CMD in the Absence of Myocardial Diseases and Obstructive CAD (2014) (2)
Response to letter from Picichè: The microvascular network connecting extracardiac arteries to the heart. (2018) (2)
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention]. (2014) (2)
Myocardial blood flow and glucose metabolism in exercise induced and spontaneous ischemia (1986) (2)
Relation of contractile reserve of hibernating myocardium to myocardial structure in humans. (2000) (2)
Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction (2005) (2)
Medical Misinformation: Vet the Message! (2019) (2)
The coronary microcirculation in left ventricular hypertrophy. (1999) (2)
[Microcirculation and remodelling]. (1994) (2)
Endothelial function in patients with chest pain and normal coronary arteries. (1997) (2)
AbstractMonday AM, April 24The pathophysiology of hibernating myocardium studied by PET during hyperinsulinemic-euglycemic clamp (1995) (2)
The beginning at the end: non-invasive assessment of post-transplant coronary allograft vasculopathy at the microcirculatory level (2018) (2)
Acute neurological dysfunction: The missing link in the pathophysiology of takotsubo syndrome. (2021) (2)
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease (1994) (2)
Non-invasive regional assessment of human cardiac beta adrenoceptors (1992) (2)
Comprar Coronary Microvascular Dysfunction | Filippo Crea | 9788847053663 | Springer (2014) (2)
Evaluation of the prospective α1-adrenoceptor radioligand, [11C]GB67, in human volunteers - Myocardial uptake and assessment of radioactive metabolites in plasma (1999) (2)
PET for Detection and Reporting Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement. (2023) (2)
["African sickness" and the heart: the mystery of endomyocardial fibrosis]. (2011) (2)
Insulin sensitivity in cardiological syndrome X (1996) (2)
The authors reply [5] (2007) (2)
Resting myocardial blood flow in patients with hibernating myocardium quantified by positron emission tomography (1997) (2)
A Novel 18F-Labeled Tracer for the Quantification of Myocardial Blood Flow and Infarct Size With Positron-Emission Tomography (2009) (2)
Blood oxygenation level-dependent magnetic resonance imaging in patients with coronary artery disease: a validation study against positron emission tomography (2008) (2)
Takotsubo: One, no one and one hundred thousand diseases. (2018) (2)
Blood oxygen level-dependent MRI in patients with coronary artery disease and normal volunteers: a validation study against PET (2009) (1)
Renal denervation in a patient with two renal accessory arteries: A case report (2013) (1)
Insights to advance our management of myocardial ischemia: From obstructive epicardial disease to functional coronary alterations (2021) (1)
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy (2021) (1)
Imaging Assessment of myocardial ischaemia and viability : role of positron emission tomography (2010) (1)
Transmural mitochondrial oxidation activities in the dog heart (1981) (1)
AbstractMonday AM, April 24Direct generation of myocardial tissue images from dynamic H2 15O scans (1995) (1)
Myocardial hibernation and heart failure: introduction (2004) (1)
[Revascularization of the hibernated myocardium: a clinical problem still unsolved]. (2012) (1)
Indirect evidence of regional differences of oxygen need within the left ventricle (1981) (1)
Coronary microcirculatory dysfunction in aortic stenosis (2001) (1)
CMD in Obstructive CAD (2014) (1)
Angina with non-obstructed coronary arteries (2019) (1)
Fluorodeoxyglucose, Myocardial Perfusion and Myocardial Cell Death—Reply (1993) (1)
Dipyridamole-induced ST segment depression in hypertrophic cardiomyopathy is associated with a reduced coronary flow response (1991) (1)
AUTOMATED ANALYSIS OF MYOCARDIAL AUTORADIOGRAPHS FOR THE STUDY OF REGIONAL GLUCOSE METABOLISM. (1980) (1)
Basic (PS01–PS58) (2012) (1)
Brief communication: Is alanine release an early marker of acute myocardial infarction? (1987) (1)
Methods to Assess Coronary Microvascular Function (2014) (1)
Microvascular Dysfunction in Hypertrophic Cardiomyopathy (2022) (1)
Medical misinformation: Vet the message! (2019) (1)
901-95 Stress-induced Subendocardial Underperfusion: A Potential Mechanism of Ischemia in Hypertrophic Cardiomyopathy (HCM) (1995) (1)
P4519Subclinical toxicity of azathioprine in patients treated for autoimmune myocarditis: a single-centre experience (2018) (1)
Vitamin C improves the coronary vasodilator reserve in asymptomatic smokers (1999) (1)
An accordion not to be played. (2015) (1)
Myocardial b-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure (2010) (1)
Chemiluminescence: A Tool To Investigate the Oxidative Stress in the Heart (1986) (1)
Viability in chronic ischaemic cardiomyopathy: need for timely revascularisation. (1999) (1)
Perindopril plus indapamide reverses coronary microvascular remodeling and improves flow in arterial hypertension (2010) (1)
Risk stratification of patients with normal myocardial perfusion imaging: help comes from the periphery. (2013) (1)
[Selective vasodilatation of the subepicardial coronary vasculature induced by carbochromen (author's transl)]. (1981) (1)
Male patients with Anderson-Fabry disease (AFD) presenting with coronary microvascular dysfunction (2004) (1)
Progressive recovery of tissue perfusion following coronary artery bypass grafting; Evidence of microvascular stunning (1997) (1)
Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study. (2022) (1)
Medical Misinformation. (2019) (1)
Positron emission tomography using F-18-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp (2001) (1)
Nuclear Cardiology (PET and SPECT): Basic Principles (2010) (1)
Scared to Death (2020) (1)
Coronary Heart Disease / Myocardial Infarction Diminished Vascular Response to Inhibition of Endothelium-Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin-1 in Clinically Healthy Smokers (2005) (1)
MODERATED POSTER SESSION: Imaging in cardiomyopathies: Friday 5 December 2014, 08:30-18:00Location: Moderated Poster area. (2014) (1)
Myocardial infarction in the young. (2012) (1)
Abstract 3357: Haemodialysis Induced Contractile Dysfunction is Associated with Acute and Reversible Reduction in Global and Segmental Myocardial Blood Flow (2007) (1)
Myocardial ischaemia and metabolic memory (2005) (1)
Perspectives in noninvasive imaging for chronic coronary syndromes. (2022) (1)
Response by Ammirati et al to Letter Regarding Article, "Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis". (2018) (1)
Myocardial metabolism in patients with chest pain and normal coronary angiograms (1992) (1)
Effects of Exogenous Adenosine on Human Coronary Circulation (1991) (1)
Role of quantitative myocardial perfusion PET as a clinical translation research tool. (2010) (1)
Effects of α1 blockade on myocardial blood flow in patients with cardiac syndrome X (1997) (1)
Multimodality imaging of mid-ventricular obstruction in left ventricular noncompaction. (2014) (1)
P620Mitral annular plane systolic excursion on cardiac magnetic resonance imaging as a predictor of atrial fibrillation in hypertrophic cardiomyopathy (2019) (1)
Effect of nifedipine on myocardial metabolism in patients with unstable angina. (1987) (1)
Unrevealing Takotsubo Syndrome: Appraising what has emerged from the International Journal of Cardiology contributions in 2019. (2019) (1)
Response by Durante and Camici to Letter Regarding Article, "Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters". (2017) (1)
Coronary vasodilator reserve in left ventricular hypertrophy. (2001) (1)
PET in the Study of Angina Pectoris (1987) (1)
Correlation between prostaglandins release and lipid peroxidation induced by oxidative stress in the isolated perfused rat heart (1985) (1)
[An unusual case of transient ST-segment elevation during hypertensive crisis in a patient with left ventricular hypertrophy]. (2012) (0)
Coronary flow reserve reduction in asymptomatic patients affected by systemic sclerosis (2013) (0)
Regional myocardial uptake of deoxyglucose and palmitic acid in conscious and anesthetized dogs (1981) (0)
Measurement of absolute subendocardlal and subepicardial blood flow in normal humans (2002) (0)
Is alanine release an early marker of acute myocardial infarction? (1987) (0)
2.2: Determinants of coronary microvascular dysfunction in symptomatic hypertrophic obstructive cardiomyopathy (2007) (0)
Correction to: Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (2022) (0)
Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance (2016) (0)
Significance of stress-induced ST segment depression in essential hypertensives with normal coronaries (1991) (0)
LV volumes and wall motion assessed with gated PET: Comparison with MUGA (1995) (0)
Abstract 618: Measurement of Absolute Myocardial Perfusion in Healthy Volunteers Using 3 Tesla Cardiac Magnetic Resonance: Validation Against Positron Emission Tomography (2009) (0)
Impairment of carbohydrate oxidation during atrial pacing in patients with syndrome X (1990) (0)
Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve (1998) (0)
Sensitive heart: A chronic cardiac pain syndrome (2015) (0)
P4509Incremental value of CMR-derived mitral annular plane systolic excursion for atrial fibrillation risk stratification in patients with hypertrophic cardiomyopathy (2017) (0)
Pre-clinical evaluation of a respiratory motion correction technique in dual gated cardiac imaging (2009) (0)
Stone heart as a consequence of a peroxidative insult (1983) (0)
The Coronary Circulation and Blood Flow in Left Ventricular Hypertrophy and in the Transition to Heart Failure (2012) (0)
Medical Misinformation. (2019) (0)
A change of scene: Paolo Camici, MD, FRCP, FESC. Interview by Emma Wilkinson. (2008) (0)
Coronary angioplasty for the treatment of chronic left ventricular dysfunction: Predictive value of positron emission tomography (1997) (0)
P1712The Impella percutaneous mechanical circulatory support device in cardiogenic shock: a single-center, real-world, observational experience (2019) (0)
Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS- (2022) (0)
[Progressive increase of the coronary flow above peak reactive hyperemia during prolonged intracoronary infusion of adenosine (author's transl)]. (1981) (0)
Effect of random coincidences for quantitative cardiac PET studies using 3D oxygen-15 water scans (2006) (0)
CORRELATION BETWEEN OXIDATIVE STRESS OF THE HEART, EVALUATED BY CHEMILUMINESCENCE EMISSION AND CONTRACTILE FUNCTION (1984) (0)
Indications for a model of coronary circulation derived from the study of transmural blood flow distribution (1979) (0)
An accordion not to be played. (2017) (0)
The balance between nitric oxide and free radicals affects the coronary vasodilator reserve (1999) (0)
Paradoxical Increase in Myocardial Perfusion After Nitric Oxide Synthase Blockade (1998) (0)
P392Preliminary evaluation of stress myocardial blood flow pattern in patients with apical hypertrophic cardiomyopathy candidate to be enrolled in the CARAPACE study. (2019) (0)
What is the Role of PET Scanning in Cardiology? (1989) (0)
Medical misinformation: vet the message! (2019) (0)
901-104 Transmural Myocardial Blood Flow Distribution and Coronary Sinus pH During Stress in Hypertrophic Cardiomyopathy (HCM) (1995) (0)
Cardiac applications of PET. (2002) (0)
Inside This Issue (2020) (0)
Impact of fibrosis and sympathetic activity on coronary flow reserve in hypertrophiccardiomyopathy (2011) (0)
P452Prognostic performance of clinical presentation and cardiac magnetic resonance ejection fraction and late enhancement pattern at basal examination in acute myocarditis (2019) (0)
Absolute quantification of cardiac blood flow measurements in pigs with the ECAT EXACT 3D and H215O: Preliminary results (1999) (0)
Abstract 3762: Myocardial Insulin Sensitivity Correlates with Sympathetic Drive in Patients with Left Ventricular Dysfunction (2006) (0)
Treatment of CMD in Obstructive CAD (2014) (0)
Parametric Polar Maps of Regional Myocardial @3-AdrenoceptorDensity (2006) (0)
[Metabolic characterization of the angina syndrome with F-18-deoxyglucose using positron tomography]. (1986) (0)
TCT-85 Prevalence of tricuspid regurgitation and its impact on mid-term outcomes: insights from a tertiary referral center. (2016) (0)
1070 PROGNOSTIC PERFORMANCE OF CARDIAC MAGNETIC RESONANCE IMAGING MARKERS VERSUS COMPLICATED CLINICAL PRESENTATION AFTER AN ACUTE MYOCARDITIS (2022) (0)
Treatment of CMD in Myocardial Diseases (2014) (0)
1032-124 Coronary microvascular dysfunction and long-term left ventricular remodeling in hypertrophic cardiomyopathy (2004) (0)
Treatment of Primary CMD (2014) (0)
Coronary reserve and left ventricular dysfunction in hypertrophic cardiomyopathy (1997) (0)
46Optimal timing for cardiovascular magnetic resonance after ST-segment elevation myocardial infarction for effective risk stratification (2019) (0)
Abstract 4845: Hypertrophic Cardiomyopathy due to Sarcomere Gene Mutations is Associated with More Severe Derangement of Microvascular Function Compared to Myofilament Negative Disease (2008) (0)
AbstractWednesday AM, April 26, 1995Myocardial blood flow distribution and ventricular tachycardia in patients with hypertrophic tachycardia in patients with hypertrophic cardiomyopathy (1995) (0)
The use of PET to assess the efficacy of gastroepiploic artery (GEA) bypass graft (1995) (0)
Blood oxygen level-dependent magnetic resonance imaging at 3 Tesla in coronary artery disease: validation using quantitative coronary angiography and cardiovascular magnetic resonance perfusion imaging (2010) (0)
Is overactivity of the sympathetic system demonstrable in Syndrome X (1995) (0)
Baseline Left Ventricular (LV) performance and functional recovery after revascularisation: Predictive value of absolute 18F Fluorodeoxyglucose (FDG) uptake (1996) (0)
Imaging of myocardial receptors : applications in the evaluation of cardiac disease (2008) (0)
P2807Repeated levosimendan infusions or LVAD as a bridge to transplantation: 2-year results (2018) (0)
Chapter 17 Chronic Ischaemic Heart Disease (2009) (0)
[Myocardial imaging with 99mTC albumin microspheres for the simultaneous assessment of contraction and perfusion in man]. (1982) (0)
The acute reduction in nitric oxide release following repetitive myocardial stunning is not associated with the production of peroxynitrite (1999) (0)
The effect on microvascular function of combined mechanical circulatory support and pharmacological therapy during induction of myocardial recovery (2003) (0)
Regional perfusion in acute myocardial infarction. (1989) (0)
Corrigendum to "Anti-anginal drugs: Systematic review and clinical implications" [Int. J. Cardiol. 283 (2019) 55-63]. (2020) (0)
2422Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis (2019) (0)
Medical Misinformation. (2019) (0)
Myocardial Ischemia & Viability (2012) (0)
Abstract 331: Non-invasive Detection of Coronary Artery Disease Using Blood Oxygen Level-dependent Magnetic Resonance Imaging at 3 Tesla (2009) (0)
MULTITRACER AUTORADIOGRAPHIC TECHNIQUE FOR IMAGING MYOCARDIAL FLOW AND METABOLISM. (1981) (0)
Gender , microvascular dysfunction , and outcomes (2014) (0)
Myocardial metabolic imaging with fluorine-18 deoxyglucose (1992) (0)
Abstract 6133: Microvascular Dysfunction and Chronic Inflammation in Patients without Cardiovascular Risk Factors (2008) (0)
Introduction IJC Special Issue on Sudden Cardiac Death. (2017) (0)
428 Prognostic implications of the relationship between effective regurgitant orifice area and left ventricle end diastolic volume in patients with functional mitral regurgitation treated with MitraClip (2020) (0)
Aortic valve sclerosis: an early marker of systemic atherosclerosis and coronary microvascular dysfunction (2013) (0)
[Indications for a model of coronary circulation derived from the study of transmural myocardial perfusion]. (1979) (0)
IMPROVING MICROVASCULAR FUNCTION IN DIABETIC PATIENTS: WHY AND HOW: PP.15.446 (2011) (0)
[Intra-arterial thrombolysis facilitated by ultrasound in submassive pulmonary embolism: first documented case report in Italy]. (2013) (0)
Abstract 2948: Evidence of Coronary Microvascular Dysfunction in patients with Systemic Inflammatory Diseases (2007) (0)
Overcoming the low yield of histology for the diagnosis of cardiac sarcoidosis. (2021) (0)
[N-methyl-11C]propionyl-L-carnitine uptake in human myocardium (1995) (0)
Hibernating myocardium is characterised by an impaired coronary vasodilator reserve (1997) (0)
ardiac Sympathetic Imaging ith m IBG in Heart Failure (0)
551Trabecular complexity as a subclinical structural alteration in fabry cardiomyopathy: a cardiac magnetic resonance study (2019) (0)
The viable myocardium [11] (1998) (0)
STATE OF THE ART IN CARDIAC POSITRON (1995) (0)
Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic beta-adrenergic receptor density with positron emission tomography (2000) (0)
18.3 Positron emission tomography to predict improvement of LVEF post-revascularization: relative merits of blood flow, glucose utilization and water-perfusable tissue fraction (2001) (0)
3D Imaging and Morphometry of the Coronary Microcirculation in Spontaneously Hypertensive Rats and Normotensive Controls (2020) (0)
Reproducibility of myocardial blood flow measurement with PET (1995) (0)
Rationale and preliminary results of the Imaging of the plaque (IMPLAC) study. A multi-modality approach to identify vulnerable carotid plaques in relation to brain damage in asymptomatic patients (2013) (0)
Glucose metabolism as a marker of myocardial ischemia (2011) (0)
Medical Misinformation: Vet the Message! (2019) (0)
Myocardial blood flow and arrhytmias in hypertrophic cardiomyopathy (1995) (0)
Ergotamine limits hyperemic myocardial blood flow in humans (1997) (0)
Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis (2014) (0)
Reproducibility of myocardial blood flow and flow reserve measurement with positron emission tomography (1999) (0)
P5196Extent and characteristics of atherosclerotic plaques and their relation to brain white matter hyperintensities in asymptomatic patients with non-obstructive carotid lesions (2017) (0)
Transforming care for rare and inherited cardiovascular diseases through education and training. (2018) (0)
Polarmaps of myocardial blood flow from dynamic 6O-159water pet-studies (1997) (0)
Cardiac Positron Emission Tomography (2002) (0)
Myocardial viability in ischemic left ventricular dysfunction. (2011) (0)
GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING) (2007) (0)
1177Insights on mitochondrial energetics in obstructive hypertrophic cardiomyopathy (2019) (0)
Iatrogenic Coronary Microvascular Dysfunction (2014) (0)
[Dual model of coronary vasodilation response to adenosine]. (1987) (0)
[Metabolism of myocardial glycogen during ischemia and reperfusion]. (1986) (0)
Gene expression profiling and enrichment functional analyses to compare coronary microvessels and cardiomyocytes in patients with hypertrophic cardiomyopathy (2020) (0)
Prevention of Iatrogenic CMD (2014) (0)
Positron emission tomography and dobutamine echocardiography for assessing viability in patients with moderate ventricular dysfunction (1997) (0)
Hemodynamic Responses to the Standard Liquid Meal in Patients With Postprandial Angina and in Control Subjects (1998) (0)
P3521T1 mapping and extracellular volume in patients with acute myocarditis: correlations with biomarkers in different clinical presentations (2017) (0)
Measurement of absolute myocardial perfusion in patients with CAD Using 3 Tesla cardiac magnetic resonance: validation against positron emission tomography (2010) (0)
IMPACT OF THE MEDITERRANEAN DIET ON PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION (2018) (0)
Advanced Cardiological Application of PET (1987) (0)
Myocardial β-adrenoceptor density 1 month after myocardial infarction predicts left ventricular remodelling (1998) (0)
Influence of respiratory motion in PET imaging (2004) (0)
P5735Feasibility and safety of Impella mechanical circulatory support in different clinical scenarios: a single-centre experience (2019) (0)
Abstract 3304: Effects Of Pioglitazone On Myocardial Blood Flow And Glucose Utilization In Non-diabetic Patients With Familial Combined Hyperlipidemia (2007) (0)
P5225Biventricular morphological and functional remodeling after percutaneous aortic valve implantation: 2d strain analysis (2017) (0)
The Pathophysiological Background of Cardiovascular Diseases and its Impact on Diagnosis and Treatment (1995) (0)
PET coronary flow reserve (2005) (0)
Use of digital phantoms to study the transmural distribution of tracers by PET (1997) (0)
Integration of New and Classical Techniques in Drug Development. PET Application to Propionyl-L-Carnitine Pharmacokinetic Study (1995) (0)
INTEGRATING HYPEREMIC MYOCARDIAL BLOOD FLOW AND CORONARY FLOW RESERVE FOR PREDICTING CARDIOVASCULAR MORTALITY OUTCOMES IN PATIENTS WITH KNOWN OR SUSPECTED ISCHEMIC HEART DISEASE (2017) (0)
Medical Misinformation. (2019) (0)
Which "Roadmap" in Patients With Advanced or Refractory Heart Failure, Eligible for LVAD and Heart Transplantation? (2018) (0)
Medical Misinformation. (2019) (0)
Nuclear cardiology (PET and SPECT)—basic principles (0)
Repeated episodes of myocardial stunning are cumulative in man (2001) (0)
Reply to the new ESC guidelines for the diagnosis and management of chronic coronary syndromes: Can we use them in practice? (2020) (0)
Relationship between regional perfusion and oxygenation in patients with coronary artery disease (2009) (0)
Myocardial blood flow in patients with anderson-fabry disease and cardiac involvement (2003) (0)
Professor Attilio Maseri died on 3 September 2021 in his native town of Udine, in the north east of Italy, where he was born 85 years ago. (2021) (0)
5903Fulminant Myocarditis treated with combined implantation of left and right percutaneous ventricular assist devices (2017) (0)
RNA‐seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy (2022) (0)
Impairment of coronary vasodilator reserve after successful angioplasty is prevented by α1-adrenoceptor blockade (1999) (0)
Erratum: Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia (European Journal of Nuclear Medicine and Molecular Imaging (2005) 32 (84-91) DOI: 10.1007/s00259-004-1621-y) (2005) (0)
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? (2002) (0)
Medical misinformation: vet the message! (2019) (0)
Cardiac volumes measured by gated pet in normal subjects (1997) (0)
No Reflow as a negative prognostic factor: its incidence and its role evalued through Cardiac Magnetic Resonance and Coronary Angiography (2014) (0)
State of the Art in Cardiac Positron Emission Tomography Wenckebach Lecture (1995) (0)
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients (2017) (0)
Prognosis of Coronary Microvascular Obstruction (2018) (0)
Medical Misinformation - Vet the Message! (2019) (0)
Abstract 15185: Impact of Sympathetic Activity and Fibrosis on Microvascular Function in Hypertrophic Cardiomyopathy (2010) (0)
Myocardial metabolism is different in syndrome X and C.A.D. patients during angina and ST depression (1991) (0)
Noninvasive assessment of the sympathetic nervous system in humans (1995) (0)
P4529Multilevel characterization of active myocarditis in athletes: a significant right ventricular involvement (2018) (0)
Measurement of Absolute Myocardial Perfusion in Healthy Volunteers Using 3 Tesla Cardiac Magnetic Resonance: Validation Against Positron Emission Tomography (2009) (0)
These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details (2014) (0)
Constancy of myocardial blood flow and pain perception over time in patients with syndrome X (1997) (0)
17"L&iv Reductlᆒni of Myoca :_41 Beta-Adrenoceptors In Hypertr,,,i_-,'-. ca:'J1ᆒmyopathy : A Study WC1h Positron Emission Tomography (2016) (0)
Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy (2000) (0)
1 Insulin resistance in patients with cardiac hypertrophy (1999) (0)
P43673D analysis of mitral annular reshape with third generation MitraClip XTr in functional and degenerative mitral regurgitation (2019) (0)
Inducible and endothelial nitric oxide synthase expression in repetitive myocardial stunning (1999) (0)
1930Occlusive inflammatory coronary microvascular disease in a patient with a complex autoimmune overlap syndrome presenting with malignant ventricular arrhythmias (2017) (0)
Imaging of microvascular disease (2021) (0)
P4728Prognostic implications of the relationship between effective regurgitant orifice area and left ventricle end diastolic volume in patients with functional mitral regurgitation treated with MitraClip (2019) (0)
Clinical evaluation of a local respiratory motion correction (LRMC) for PET/CT imaging (2009) (0)
[Guidelines for percutaneous coronary interventions]. (2005) (0)
[The distribution of the coronary flow with a perfusion pressure superior to the left ventricular systolic pressure]. (1976) (0)
[Effect of contraction on the distribution of coronary flow]. (1976) (0)
Medical Misinformation. (2019) (0)
Clinical Progress Series Pathophysiological Dilemma of Syndrome X (2005) (0)
P2974Late gadolinium enhancement, reverse remodeling and prognosis in patients with non-ischemic dilated cardiomyopathy and moderate-to-severe systolic dysfunction (2017) (0)
Updates on MINOCA and INOCA through the 2022 publications in the International Journal of Cardiology. (2023) (0)
P5273Trabecular complexity as a subclinical structural alteration in Fabry cardiomyopathy: a cardiac magnetic resonance study (2019) (0)
infarctionpredicts left ventricular volumes at six months Myocardial beta-adrenoceptor densityone month after acute myocardial (2011) (0)
P4526Multimodal diagnosis in clinically suspected myocarditis: behind discordancy between endomyocardial biopsy and cardiac magnetic resonance (2018) (0)
Abstract 2240: T2-Prepared Steady-State Free-Precession Blood Oxygenation Level-Dependent MRI in Patients with Coronary Artery Disease and Normal Volunteers: Validation against PET (2008) (0)
[Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve]. (2003) (0)
Severely impaired coronary reserve rather than resting hypoperfusion characterises hibernating myocardium (1997) (0)
Coronary flow reserve in muscle dystrophies. (1997) (0)
Synthesis and preclinical evaluation of iodine-125 and iodine-124 labelled human insulin (1999) (0)
P4525PET scan in myocarditis: patient selection, diagnostic performance and role in disease monitoring (2018) (0)
Influence of selective autonomic decentralization on myocardial deoxyglucose uptake initiated by cardio-cardiac reflexes (1992) (0)
Impaired Myocardial Utilization of Lactate and Pyruvate in Different Patients with Microvascular Angina (1994) (0)
DIGITAL IMAGINE OF MYOCARDIAL METABOLISM BY A MULTIWIRE PROPORTIONAL CHAMBER: AN ALTERNATIVE TO AUTORADIOGRAPHY. (1983) (0)
CMD in Myocardial Diseases (2014) (0)
The Coronary Microcirculation and Myocardial Ischemia (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paolo Guido Camici?

Paolo Guido Camici is affiliated with the following schools:

Paolo Guido Camici's Academic­Influence.com Rankings

Why Is Paolo Guido Camici Influential?

Paolo Guido Camici's Published Works

Published Works

What Schools Are Affiliated With Paolo Guido Camici?

Paolo Guido Camici's AcademicInfluence.com Rankings